Coagulation Disorder Clinical Trial
Official title:
Current Situation of the Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment in GHPSJ (St Joseph's Hospital)
Verified date | September 2017 |
Source | Groupe Hospitalier Paris Saint Joseph |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Oral antigoagulant are used more than 60 years in thrombotic diseases. Even they are
indispensable, the haemorragic risk is high.That's why it's the main reason of
hospitalization for iatrogeny.The complication's reasons are mainly linked to errors of drug
intake, drugs interaction and the lack of understanding the treatment.Moreover, the
antiplatelet agglutening treatment is frequently added to anticoagulant treatment.This
increases the haemorragic risk.Different means were used to minimize the risk , like INR
follow up.
The purpose of the study is to evaluate smartphone use to follow the patients'treatment.
Status | Completed |
Enrollment | 100 |
Est. completion date | October 30, 2016 |
Est. primary completion date | July 31, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patient under ant-thrombotic treatment - hospitalized in vascular medecine service Exclusion Criteria: - refusing the participation |
Country | Name | City | State |
---|---|---|---|
France | Groupe Hospitalier Paris Saint Joseph | Paris | Ile-de-France |
Lead Sponsor | Collaborator |
---|---|
Groupe Hospitalier Paris Saint Joseph |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | smartphone use level | evaluation of the interest of patient to use their smartphone in the purpose to follow their anticoagulant treatment | 15 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03826043 -
THrombo-Embolic Event in Onco-hematology
|
N/A | |
Recruiting |
NCT04274777 -
The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
|
||
Recruiting |
NCT03136510 -
Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
|
N/A | |
Completed |
NCT01588132 -
Anfibatide Phase 1 Clinical Trial in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04488341 -
Effect of Aerobic Exercises on Sex Hormones and Coagulation Factors in Postmenopausal Elderly Women
|
N/A | |
Recruiting |
NCT04524637 -
The Utility of Thromboelastography in Traumatic Brain Injury
|
||
Completed |
NCT03634215 -
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
|
||
Completed |
NCT05152420 -
Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects
|
Phase 1 | |
Recruiting |
NCT05645081 -
Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
|
||
Completed |
NCT04322721 -
Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients
|
||
Completed |
NCT03267823 -
INR Comparison Testing in Cardiac Surgery
|
||
Completed |
NCT04490759 -
QStat Pilot Reference Range Study
|
||
Completed |
NCT04107818 -
Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.
|
||
Recruiting |
NCT05484830 -
Coagulation in Acute Aortic Dissection
|
N/A | |
Recruiting |
NCT04111120 -
Heparin Like Effect in Acute Variceal Bleeding
|
||
Completed |
NCT05162339 -
Inflammatory Bowel Disease and Thromboembolic Events
|
||
Completed |
NCT03555630 -
Thromboelastogram in Postdelivery Preeclamptic Patients
|
||
Completed |
NCT01589172 -
Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury
|
||
Recruiting |
NCT04278404 -
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
|
||
Completed |
NCT03956836 -
Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)
|